乳腺瘤在扩张期间保持亚克隆多样性的储备
Darlan C Minussi1,2, Michael D Nicholson3,4,5, Hanghui Ye1,2
1Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Nature
|March 25, 2021
概括
三重阴性乳腺癌表现出显著的亚克隆多样性和正在进行的基因组进化. 单细胞测序显示了原发性瘤中复杂的拷贝数变化和多样化.
科学领域:
- 基因组学
- 癌症生物学
- 进化生物学
背景情况:
- 在初级乳腺瘤生长过程中对副本数量变化的理解有限.
- 需要对瘤异质性的高分辨率分析.
研究的目的:
- 在单细胞分辨率下研究三阴性乳腺癌的拷贝数演变.
- 描述主要瘤的亚克隆结构和进化动态.
主要方法:
- 开发了一种单细胞单分子DNA测序方法.
- 对来自人类三阴性乳腺癌和细胞系的16178个单细胞进行复制数分析.
主要成果:
- 每个瘤分为3-5个主要超级克隆的7-22个子克隆.
- 观察到TP53突变后的基因组翻倍和暂时的基因组不稳定性.
- 证明了瘤细胞基因组的持续复制数演变和多样化.
结论:
- 在初级瘤扩张期间,三阴性乳腺癌保持了大量的亚克隆多样性.
- 瘤细胞不断演变染色体异常,并没有保持同源性.
- 单细胞测序为乳腺癌的演变提供了重要的洞察力.
相关概念视频
Tumor Progression
6.8K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.8K
Cancer Stem Cells and Tumor Maintenance
5.2K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.2K
Cancer
51.6K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.6K
Cancers Originate from Somatic Mutations in a Single Cell
13.4K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
13.4K
Adaptive Mechanisms in Cancer Cells
6.1K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.1K
Metastasis
6.0K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.0K


